Researchers report that deactivating a single gene in pancreatic duct cells enables them to produce insulin, suggesting a potential diabetes therapy.

"Deactivating one gene lets pancreatic duct cells produce insulin, a potential diabetes treatment" — Wired · Science & Medicine

27 Sept 2026

View source

What it means

Researchers at Harvard Medical School identified a gene called that acts like a molecular brake, keeping in their default, non-insulin-producing state. By deactivating this single gene, they enabled those duct cells to start producing insulin, a potential step toward a long-term diabetes treatment that could bypass the need for insulin injections or transplants.

Accuracy & sourcesGrounded

The claim is based on a peer-reviewed study from Harvard Medical School, which Wired reports on as a reputable secondary source. The primary finding—that disabling ALDH3B2 can reprogram pancreatic duct cells to produce insulin—is solidly supported by the study's data, as confirmed by multiple outlets covering the same research.

How new

The Wired article and the underlying study were published in late September 2026, making this genuinely new research.

Researchers report that deactivating a single gene in pancreatic duct cells enables them to produce insulin, suggesting a potential diabetes therapy.

What it means

Accuracy & sourcesGrounded

How new

Go deeper